还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

% F7 ]9 f# L1 X9 l4 R                               
登录/注册后可看大图

请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

& h2 U. b9 z& g8 q可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  

0 I& p: p: J% T7 \
, O/ L& h* _: R% |$ E; bSub-category:
Molecular Targets
# \4 J7 ]0 r- x
' B% L& H5 C- N1 g5 _" A3 A3 b
Category:
/ d/ g# n! e9 c" ~Tumor Biology

/ F2 j# p. Z8 p' I" ^" L
Meeting:
1 Q* C9 a; n0 E9 l" g2011 ASCO Annual Meeting
0 z7 u* ~* A$ h( i7 B6 O3 ?
; |; _/ U" X2 k3 w1 i1 o
Session Type and Session Title:
Poster Discussion Session, Tumor Biology
; [& S( \, |$ t0 ~/ y- `7 ^- E
2 s. K- C) P2 c" w, {
Abstract No:
10517
2 `- i% U$ P8 ~. t9 X8 A4 M( u

' H3 ~! C; R1 w6 YCitation:
J Clin Oncol 29: 2011 (suppl; abstr 10517)

2 k8 u5 q+ y' k; A
5 w# Y" [8 A/ GAuthor(s):
9 G; o4 X; l- @  V; [3 {% s$ J2 g% WJ. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
( p' o9 d( g! U$ @

* T. U4 u1 U. G
Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.
  N5 w4 u! E2 b$ t9 {" V  n; q
% v3 H, s0 ]0 P! @) S3 G! KAbstract Disclosures

/ V" ^- c) Q! o5 |' g6 n1 NAbstract:

7 a' C% b* V" H
Background: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.
/ ^1 M5 }9 p) n; p0 L
$ E* }, [  e) d' q

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

3 e4 r9 q9 M9 q没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
4 f: C- n7 Q8 L3 T$ z9 GALK一个指标医院要900多 ...

平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
: b- E8 O& ~/ A% s0 h: X( C
9 c# [. H3 v- V7 m现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊